Transgenomic, Inc. TBIO Company Overview  Stock Message

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Transgenomic, Inc. TBIO Company Overview 

Stock Message Board http://investorshangout.com/search?q=TBIO&...mp;yt1=Go!

Transgenomic, Inc. TBIO Current Price and Quotes
Last Price 0.38
Previous Close 0.36 Open 0.36
Daily Range 0.38 - 0.36 52wk Range 0.999 - 0.302
Volume 9,000 Dividend N/A
Average Vol (3m) 83,875 Yield N/A
Transgenomic, Inc. TBIO
Company Information

12325 Emmet Street
Omaha, NE 68164

Website: http://www.transgenomic.com
Phone: (402) 452-5430
Email: info@transgenomic.com

Transgenomic, Inc. TBIO
TRANSGENOMIC is a global biotechnology company that provides unique products and services for automated high sensitivity genetic variation and mutation analysis. Our offering includes systems, products, discovery and laboratory testing services to the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine.

Transgenomic, Inc. TBIO
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001043961
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 3826 - Analytical instruments
Incorporated In: DE, USA
Year of Inc. 1997
Employees 165 a/o Aug 02, 2011
Company Officers/Contacts

Craig Tuttle CEO, President
Mark P. Colonnese CFO
Chad Richards Chief Comm. Officer
Investor Relations IR
Company Directors

Not Available
Service Providers

Auditor/Accountant
Ernst & Young LLP
5 Times Square
New York, NY, 10036-6530
United States

Legal Counsel
Abrahams Kaslow & Cassman LLP
8712 West Dodge Road
Omaha, NE, 68114
United States

Investor Relations Firm
Not Available

Transgenomic, Inc. TBIO
TBIO Security Details

Share Structure

Market Value1 $33,533,376 a/o Sep 13, 2013
Shares Outstanding 88,245,725 a/o Aug 07, 2013
Float Not Available
Authorized Shares 100,000,000 a/o Aug 02, 2011
Par Value  0.01
Shareholders

Shareholders of Record 3,200 a/o Mar 14, 2013
Security Notes

New Issue=7-00 5,152,000 shs at $15 by Chase H & Q et al.
Note=2-22-07 deleted from NASDAQ
Short Selling Data

Short Interest 102,976 (7.64%)
Aug 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Wells Fargo Shareholder Services (Minneapolis, MN)

Transgenomic, Inc. TBIO Recent News

Sept 6, 2013 OTC Daily Alert Stock Watch - Transgenomic, Inc. (OTCQB: TBIO)
Aug 8, 2013 Quest Diagnostics Introduces Comprehensive Opioid Therapy Genetic Test Based on CYP450 Biomarker License with Transgenomic
Aug 7, 2013 Transgenomic Reports Second Quarter 2013 Financial Results
Aug 6, 2013 Reminder: Transgenomic to Hold Second Quarter Financial Results Conference Call on August 6, 2013
Jul 30, 2013 Transgenomic to Hold Second Quarter Financial Results Conference Call on August 6, 2013


Transgenomic, Inc. TBIO Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 31,480 31,971 20,048 22,023
Cost of Revenue 16,470 13,534 10,284 10,418
Gross Profit 15,010 18,437 9,764 11,605
Operating Expenses

Research and Development 2,491 2,218 2,305 3,182
Sales, General and Admin. 22,023 19,150 10,933 10,319
Non-Recurring Items - 41 138 -
Other - - - -
Operating Income (9,504) (2,972) (3,612) (1,896)
Income From Continuing Operations

Add'l Income/Expense Items 2,211 (5,807) 632 3
Earnings Before Interest and Tax (8,181) (9,737) (2,984) (1,878)
Interest Expense - - - -
Earnings Before Tax (8,181) (9,737) (2,984) (1,878)
Income Tax 146 45 150 42
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (8,327) (9,782) (3,134) (1,920)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (8,327) (9,782) (3,134) (1,920)
Preferred Stock and Other Adjustments (660) (1,010) - -
Net Income Applicable to Common Shareholders (8,987) (10,792) (3,134) (1,920)

TBIO Transgenomic, Inc. Research DD Guide

TBIO Transgenomic, Inc. Stock Message Board http://investorshangout.com/search?q=TBIO&...mp;yt0=Go!
TBIO Transgenomic, Inc. Stock Quote http://www.otcmarkets.com/stock/TBIO/quote
TBIO Transgenomic, Inc. Stock Chart http://www.otcmarkets.com/stock/TBIO/chart
TBIO Transgenomic, Inc. Company Info http://www.otcmarkets.com/stock/TBIO/company-info
TBIO Transgenomic, Inc. Recent News http://www.otcmarkets.com/stock/TBIO/news
TBIO Transgenomic, Inc. Financials http://www.otcmarkets.com/stock/TBIO/financials
TBIO Transgenomic, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/TBIO/filings
TBIO Transgenomic, Inc. Short Sales http://www.otcmarkets.com/stock/TBIO/short-sales
TBIO Transgenomic, Inc. Insider Disclosure http://www.otcmarkets.com/stock/TBIO/insider-transactions
TBIO Transgenomic, Inc. Research Reports http://www.otcmarkets.com/stock/TBIO/research
TBIO Transgenomic, Inc. Summary http://finance.yahoo.com/q?s=TBIO
TBIO Transgenomic, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=TBIO+Historical+Prices
TBIO Transgenomic, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=TBIO
TBIO Transgenomic, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=TBIO+Basic+Chart
TBIO Transgenomic, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=TBIO+Basic+Tech.+Analysis
TBIO Transgenomic, Inc. Headlines http://finance.yahoo.com/q/h?s=TBIO+Headlines
TBIO Transgenomic, Inc. Press Releases http://finance.yahoo.com/q/p?s=TBIO+Press+Releases
TBIO Transgenomic, Inc. Company Profile http://finance.yahoo.com/q/pr?s=TBIO+Profile
TBIO Transgenomic, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=TBIO+Key+Statistics
TBIO Transgenomic, Inc. Industry http://finance.yahoo.com/q/in?s=TBIO+Industry
TBIO Transgenomic, Inc. Major Holders http://finance.yahoo.com/q/mh?s=TBIO+Major+Holders
TBIO Transgenomic, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=TBIO+Insider+Transactions
TBIO Transgenomic, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=TBIO+Insider+Roster
TBIO Transgenomic, Inc. Income Statement http://finance.yahoo.com/q/is?s=TBIO
TBIO Transgenomic, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=TBIO
TBIO Transgenomic, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=TBIO+Cash+Flow&annual
TBIO Transgenomic, Inc. Nasdaq http://www.nasdaq.com/symbol/TBIO
TBIO Transgenomic, Inc. Market Watch http://www.marketwatch.com/investing/stock/TBIO
TBIO Transgenomic, Inc. Bloomberg http://www.bloomberg.com/quote/TBIO:US
TBIO Transgenomic, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=TBIO
TBIO Transgenomic, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=TBIO
TBIO Transgenomic, Inc. Barchart http://www.barchart.com/quotes/stocks/TBIO
TBIO Transgenomic, Inc. OTC Short Report http://otcshortreport.com/index.php?index=TBIO
TBIO Transgenomic, Inc. Investopedia http://www.investopedia.com/markets/stocks/TBIO/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Market Expansion of Utility Solar Trackers: Future Insights

Updated Category News Views 247

Utility Solar Tracker Market Growth Prospects The utility solar tracker market is projected to reach an impressive USD 34.6 billion in the coming years. This growth is largely driven by the declining costs of photovoltaic (PV) panels, which have significantly lowered the financial barriers for solar energy projects. As PV panels become more affordable, the opportunity for...

Continue Reading
UVA Cancer Center Joins Caris Precision Oncology Alliance

Updated Category News Views 59

UVA Cancer Center Joins the Caris Precision Oncology Alliance UVA Cancer Center has officially joined the Caris Precision Oncology Alliance (Caris POA), a significant network dedicated to advancing precision medicine and cancer treatment. Caris Life Sciences is thrilled to welcome this esteemed institution, recognized for its commitment to enhancing patient outcomes...

Continue Reading
Investors Show Strong Confidence in Spotify Technology's Future Potential

Updated Category News Views 116

High-Rolling Investors Stake Their Bets on Spotify Technology In recent developments, it's evident that significant investors have adopted a bullish stance on Spotify Technology. This movement warrants attention from retail traders and those interested in stock market dynamics. Overview of Options Activity Tracking the latest trends, we've noted a remarkable surge in...

Continue Reading
Johnson & Johnson's Groundbreaking CAR T-Cell Therapy Data Unveiled

Updated Category News Views 191

Johnson & Johnson’s CAR T-Cell Therapy Demonstrates Promise in Lymphoma In a recent Phase 1b study, Johnson & Johnson (NYSE: JNJ) revealed the first clinical results of its investigational dual-targeting CAR T-cell therapy, JNJ-90014496, specifically aimed at treating patients with relapsed or refractory large B-cell lymphoma (R/R LBCL). This early data suggests a...

Continue Reading
Booking Holdings Prepares for Upcoming Earnings Report

Updated Category News Views 143

Booking Holdings Set for Earnings Announcement Booking Holdings (NASDAQ: BKNG) is gearing up to share its quarterly earnings. Investors are keenly awaiting this announcement, which is expected to be significant for market sentiment and share price movements. Expected Earnings Per Share According to analysts, Booking Holdings is projected to report an impressive earnings...

Continue Reading